BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31144472)

  • 21. Thiamine-responsive megaloblastic anemia syndrome with Ebstein anomaly: a case report.
    Akbari MT; Zare Karizi S; Mirfakhraie R; Keikhaei B
    Eur J Pediatr; 2014 Dec; 173(12):1663-5. PubMed ID: 24357267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted disruption of Slc19a2, the gene encoding the high-affinity thiamin transporter Thtr-1, causes diabetes mellitus, sensorineural deafness and megaloblastosis in mice.
    Oishi K; Hofmann S; Diaz GA; Brown T; Manwani D; Ng L; Young R; Vlassara H; Ioannou YA; Forrest D; Gelb BD
    Hum Mol Genet; 2002 Nov; 11(23):2951-60. PubMed ID: 12393806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel mutation in the SLC19A2 gene in an African-American female with thiamine-responsive megaloblastic anemia syndrome.
    Lagarde WH; Underwood LE; Moats-Staats BM; Calikoglu AS
    Am J Med Genet A; 2004 Mar; 125A(3):299-305. PubMed ID: 14994241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thiamine responsive megaloblastic anemia with a novel SLC19A2 mutation presenting with myeloid maturational arrest.
    Dua V; Yadav SP; Kumar V; Khan AA; Puri R; Verma I; Flanagan SE; Ellard S; Sachdeva A
    Pediatr Blood Cancer; 2013 Jul; 60(7):1242-3. PubMed ID: 23512295
    [No Abstract]   [Full Text] [Related]  

  • 25. Thiamine Responsive Megaloblastic Anaemia, Diabetes Mellitus and Sensorineural Hearing Loss in a Child.
    Khurshid A; Fatimah S; Altaf C; Malik HS; Sajjad Z; Khadim MT
    J Coll Physicians Surg Pak; 2018 Sep; 28(9):S169-S171. PubMed ID: 30173687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel mutation in the SLC19A2 gene in a Turkish female with thiamine-responsive megaloblastic anemia syndrome.
    Yeşilkaya E; Bideci A; Temizkan M; Kaya Z; Camurdan O; Koç A; Bozkaya D; Koçak U; Cinaz P
    J Trop Pediatr; 2009 Aug; 55(4):265-7. PubMed ID: 18614593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thiamine-responsive megaloblastic anemia syndrome.
    Bay A; Keskin M; Hizli S; Uygun H; Dai A; Gumruk F
    Int J Hematol; 2010 Oct; 92(3):524-6. PubMed ID: 20835854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness.
    Labay V; Raz T; Baron D; Mandel H; Williams H; Barrett T; Szargel R; McDonald L; Shalata A; Nosaka K; Gregory S; Cohen N
    Nat Genet; 1999 Jul; 22(3):300-4. PubMed ID: 10391221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thiamine-responsive megaloblastic anemia or Rogers syndrome: A literature review].
    Lu H; Lu H; Vaucher J; Tran C; Vollenweider P; Castioni J
    Rev Med Interne; 2019 Jan; 40(1):20-27. PubMed ID: 30031565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter.
    Fleming JC; Tartaglini E; Steinkamp MP; Schorderet DF; Cohen N; Neufeld EJ
    Nat Genet; 1999 Jul; 22(3):305-8. PubMed ID: 10391222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of plasma membrane targeting of a G172D mutant thiamine transporter derived from Rogers syndrome family.
    Baron D; Assaraf YG; Cohen N; Aronheim A
    Mol Med; 2002 Aug; 8(8):462-74. PubMed ID: 12435857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thiamine-responsive megaloblastic anemia syndrome with atrial standstill: a case report.
    Aycan Z; Baş VN; Cetinkaya S; Ağladioğlu SY; Kendirci HN; Senocak F
    J Pediatr Hematol Oncol; 2011 Mar; 33(2):144-7. PubMed ID: 21285901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Defect of thiamine transport and activation and related disease].
    Xian X; Lin F
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Feb; 35(1):121-124. PubMed ID: 29419877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thiamine-responsive megaloblastic anemia syndrome: a novel mutation.
    Yilmaz Agladioglu S; Aycan Z; Bas VN; Peltek Kendirci HN; Onder A
    Genet Couns; 2012; 23(2):149-56. PubMed ID: 22876572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancytopenia in an adult patient with thiamine-responsive megaloblastic anaemia.
    Moulin V; Grandoni F; Castioni J; Lu H
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29903777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 50 Years Ago in The Journal of Pediatrics: Thiamine-Responsive Megaloblastic Anemia.
    Mullikin D; Grimes AB
    J Pediatr; 2019 Apr; 207():53. PubMed ID: 30922504
    [No Abstract]   [Full Text] [Related]  

  • 37. Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport.
    Neufeld EJ; Fleming JC; Tartaglini E; Steinkamp MP
    Blood Cells Mol Dis; 2001; 27(1):135-8. PubMed ID: 11358373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thiamine-responsive megaloblastic anaemia: a cause of syndromic diabetes in childhood.
    Olsen BS; Hahnemann JM; Schwartz M; Østergaard E
    Pediatr Diabetes; 2007 Aug; 8(4):239-41. PubMed ID: 17659067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thiamine-responsive megaloblastic anemia: early diagnosis may be effective in preventing deafness.
    Onal H; Bariş S; Ozdil M; Yeşil G; Altun G; Ozyilmaz I; Aydin A; Celkan T
    Turk J Pediatr; 2009; 51(3):301-4. PubMed ID: 19817279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome.
    Diaz GA; Banikazemi M; Oishi K; Desnick RJ; Gelb BD
    Nat Genet; 1999 Jul; 22(3):309-12. PubMed ID: 10391223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.